Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Expert Opinion on Drug Safety
|
November 21, 2018
Safety of osimertinib in EGFR-mutated non-small cell lung cancer
Laura Mezquita, Andreea Varga, David Planchard
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges
Ioan Tilea, Andreea Varga, Razvan Constantin Serban
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)
|
March 11, 2022
The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review
Mariana Cornelia Tilinca, Maximilian Cosma Gliga, Andreea Varga
Journal of Personalized Medicine
|
December 24, 2021
The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Ioan Tilea, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)
|
November 1, 2021
Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients - An Ongoing Approach
Ioan Tilea, Andreea Varga, Anca-Meda Georgescu, et al.
Medicina (Kaunas, Lithuania)
|
July 2, 2021
A 2021 Update on the Use of Liraglutide in the Modern Treatment of 'Diabesity': A Narrative Review
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Alexandru Burlacu, et al.
Patient Preference and Adherence
|
May 8, 2018
Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania
Ioan Tilea, Dorina Petra, Septimiu Voidazan, et al.
Experimental and Therapeutic Medicine
|
September 10, 2021
Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review)
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Cristina Niculas, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on "Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). <i>Diagnostics</i> 2025, <i>15</i>, 2126"
Dragos Gabriel Iancu, Liviu Cristescu, Razvan Gheorghita Mares, et al.
Diagnostics (Basel, Switzerland)
|
March 13, 2025
Proposed Novel Heart Failure Biomarkers and Their Association with Length of Hospital Stay and Mortality: A Retrospective Observational Pilot Study
Liviu Cristescu, Dragos-Gabriel Iancu, Marius-Stefan Marusteri, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Expert Opinion on Drug Safety
|
November 21, 2018
Safety of osimertinib in EGFR-mutated non-small cell lung cancer
Laura Mezquita, Andreea Varga, David Planchard
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges
Ioan Tilea, Andreea Varga, Razvan Constantin Serban
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)
|
March 11, 2022
The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review
Mariana Cornelia Tilinca, Maximilian Cosma Gliga, Andreea Varga
Journal of Personalized Medicine
|
December 24, 2021
The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Ioan Tilea, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)
|
November 1, 2021
Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients - An Ongoing Approach
Ioan Tilea, Andreea Varga, Anca-Meda Georgescu, et al.
Medicina (Kaunas, Lithuania)
|
July 2, 2021
A 2021 Update on the Use of Liraglutide in the Modern Treatment of 'Diabesity': A Narrative Review
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Alexandru Burlacu, et al.
Patient Preference and Adherence
|
May 8, 2018
Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania
Ioan Tilea, Dorina Petra, Septimiu Voidazan, et al.
Experimental and Therapeutic Medicine
|
September 10, 2021
Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review)
Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Cristina Niculas, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on "Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). <i>Diagnostics</i> 2025, <i>15</i>, 2126"
Dragos Gabriel Iancu, Liviu Cristescu, Razvan Gheorghita Mares, et al.
Diagnostics (Basel, Switzerland)
|
March 13, 2025
Proposed Novel Heart Failure Biomarkers and Their Association with Length of Hospital Stay and Mortality: A Retrospective Observational Pilot Study
Liviu Cristescu, Dragos-Gabriel Iancu, Marius-Stefan Marusteri, et al.
Page
of 5